Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Piramal Pharma Solutions Achieves Regulatory Compliance for Nitrosamine Impurities

Contributed by: PR Newswire

Images

PR Newswire associated0
PR Newswire associated1

Tags

Piramal-Pharma

More Like This

PR Newswire associated0

Piramal Pharma Solutions Launches In-Vitro Biology Capabilities at Ahmedabad Discovery Services Site

PR Newswire associated0

Piramal Pharma Solutions Achieves Revenue Threshold on Innovation Work

PR Newswire associated0

Piramal Pharma Limited Announces Consolidated Results for Q1FY25

PR Newswire associated0

Piramal Pharma Limited Announces Results for Q1FY26

PR Newswire associated0

Piramal Pharma Solutions Breaks Ground on $90M Expansion Plan

PR Newswire associated0

Piramal Pharma Solutions and NewAmsterdam Pharma Invest in Dedicated Suite to Enhance Oral Solid Dosage Production Capabilities at Piramal's Sellersville, Pennsylvania Site

PR Newswire associated0

Piramal Pharma Publishes FY2025 Sustainability Report, Outlining Performance and Decarbonization Glidepath

PR Newswire associated0

Piramal Pharma Limited Announces Results for Q3 and 9M FY25

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2025

Terms of Use

Privacy Policy

Contact Us